Wednesday, June 10, 2026
🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
2,004

Quick answer

2,004 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6287537

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6281196

    Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated agelagalastatin

    THE ARIZONA BOARD OF REGENTS · Granted Tue Aug 28 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6277368

    Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine

    The Regents of the University of California · Granted Tue Aug 21 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6274729

    Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis

    THE ARIZONA BOARD OF REGENTS · Granted Tue Aug 14 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6270778

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6268350

    Polynucleotides for inhibiting metastasis and tumor cell growth

    BioCrystal, Ltd. · Granted Tue Jul 31 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6262242

    Tumor suppressor designated TS10Q23.3

    The Board of Regents of the University of Texas System · Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6261831

    Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat

    United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6261791

    Method for diagnosing cancer using specific PSCA antibodies

    The Regents of the University of California · Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6261535

    Diagnostic methods for targeting the vasculature of solid tumors

    THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6258845

    DFMO and sulindac combination in cancer chemoprevention

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6255105

    Nucleotide and deduced amino acid sequences of tumor gene Int6

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6251871

    P16 expression constructs and their application in cancer therapy

    The Board of Regents of the University of Texas System · Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6252093

    Total synthesis of antitumor acylfulvenes

    The Regents of the University of California · Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6248351

    Human PEA3 is a tumor suppressor for cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6232086

    Method for detecting cancer cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 15 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6224866

    Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors

    BioCrystal, Ltd. · Granted Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6210917

    Method for suppressing multiple drug resistance in cancer cells

    The Regents of the University of California · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6211239

    Method for treating or preventing breast cancer or leukemia using 6-[3-[1-adamantyl]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN)

    Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6207147

    Cancer immunotherapy using tumor cells combined with mixed lymphocytes

    The Regents of the University of California · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6207821

    Long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis

    THE ARIZONA BOARD OF REGENTS · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6207690

    Troglitazone compounds for treating climacteric and cancer

    The Board of Regents of the University of Texas System · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6203787

    Treating tumors using implants comprising combinations of allogeneic cells

    The Regents of the University of California · Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6200597

    Formulation and use of carotenoids in treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6201129

    Tricyclic derivatives and their use as anti-cancer agents

    Univ. College Cardiff Consultants · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6200765

    Non-invasive methods to detect prostate cancer

    Pacific Northwest Cancer Foundation · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6197754

    Suppression of tumor growth by a mini-E1A gene

    The Board of Regents of the University of Texas System · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6193963

    Method of treating tumor-bearing patients with human plasma hyaluronidase

    The Regents of the University of California · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6187313

    Composition and method for treating and preventing helicobactor-pylori-associated stomach gastritis, ulcers and cancer

    Nature's Sunshine Products, Inc. · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6187306

    Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6184224

    Antitumor dibenzofluorene derivatives

    The Board of Regents of the University of Texas System · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6183727

    Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis

    THE ARIZONA BOARD OF REGENTS · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6172212

    Pea3 is a tumor suppressor

    The Board of Regents of the University of Texas System · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6165440

    Radiation and nanoparticles for enhancement of drug delivery in solid tumors

    The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6162897

    17q-linked breast and ovarian cancer susceptibility gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6160184

    Total synthesis of antitumor acylfulvenes

    The Regents of the University of California · Granted Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6156321

    Tissue factor methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6155266

    Method for treatment of cancer and infectious disease

    Maxim Pharmaceuticals, Inc. · Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6153430

    Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6150398

    Methods for the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6149918

    Human herpesvirus type 8 isolated from human lymphoma cell line

    The Regents of the University of California · Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6149904

    Method for inhibiting tumor cell growth by administering to tumor cells expressing a nucleic acid encoding a connexin and a pro-drug

    The Regents of the University of California · Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6147060

    Treatment of carcinomas using squalamine in combination with other anti-cancer agents

    Magainin Pharmaceuticals Inc. · Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6143290

    Tumor regression by adenovirus expression of wild-type p53

    The Board of Regents of the University of Texas System · Granted Tue Nov 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6136306

    Method for treating tumors

    The Regents of the University of California · Granted Tue Oct 24 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6132730

    Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6132980

    Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6132729

    Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

2,004 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.